Paul Mahon
General Counsel bij UNITED THERAPEUTICS CORPORATION
Vermogen: 8 M $ op 29-02-2024
Profiel
Paul A.
Mahon is Secretary, Executive VP & General Counsel for United Therapeutics Corp., Co-Managing Director at Unither Therapeutik GmbH (a subsidiary of United Therapeutics Corp.) and Secretary, Executive VP & General Counsel of Miromatrix Medical, Inc.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
21-03-2024 | 36 710 ( 0.08% ) | 8 M $ | 29-02-2024 |
Actieve functies van Paul Mahon
Bedrijven | Functie | Begin |
---|---|---|
UNITED THERAPEUTICS CORPORATION | General Counsel | 01-01-2001 |
MIROMATRIX MEDICAL INC. | General Counsel | 11-12-2023 |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Part of United Therapeutics Corp., Unither Therapeutik GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Morfelden-Walldorf, Germany. The CEOs of the company are Paul A. Mahon, James Christopher Edgemond. | Chief Executive Officer | - |
Eerdere bekende functies van Paul Mahon
Bedrijven | Functie | Einde |
---|---|---|
STEADYMED LTD | Director/Board Member | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
UNITED THERAPEUTICS CORPORATION | Health Technology |
MIROMATRIX MEDICAL INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Part of United Therapeutics Corp., Unither Therapeutik GmbH is a German pharmaceutical company that manufactures pharmaceutical products. The private company is based in Morfelden-Walldorf, Germany. The CEOs of the company are Paul A. Mahon, James Christopher Edgemond. | Health Technology |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |